Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 03:59PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.43 Insider Own- Shs Outstand16.39M Perf Week-7.10%
Market Cap75.07M Forward P/E- EPS next Y0.00 Insider Trans- Shs Float- Perf Month-17.03%
Income-7.05M PEG- EPS next Q- Inst Own3.90% Short Float- Perf Quarter-26.48%
Sales56.89M P/S1.32 EPS this Y51.85% Inst Trans- Short Ratio0.21 Perf Half Y-47.36%
Book/sh4.49 P/B1.02 EPS next Y100.00% ROA-6.30% Short Interest0.00M Perf Year-53.71%
Cash/sh1.60 P/C2.86 EPS next 5Y- ROE-10.91% 52W Range4.06 - 11.52 Perf YTD-42.57%
Dividend Est.- P/FCF- EPS past 5Y- ROI-7.94% 52W High-60.24% Beta-0.62
Dividend TTM- Quick Ratio2.08 Sales past 5Y4.10% Gross Margin44.26% 52W Low12.81% ATR (14)0.29
Dividend Ex-Date- Current Ratio2.30 EPS Y/Y TTM-8263.46% Oper. Margin-11.92% RSI (14)42.66 Volatility1.71% 2.61%
Employees583 Debt/Eq0.27 Sales Y/Y TTM-3.12% Profit Margin-12.40% Recom1.00 Target Price11.00
Option/ShortNo / Yes LT Debt/Eq0.21 EPS Q/Q- Payout- Rel Volume0.00 Prev Close4.91
Sales Surprise1.96% EPS Surprise-42.11% Sales Q/Q- EarningsApr 17 BMO Avg Volume2.74K Price4.58
SMA20-10.12% SMA50-10.42% SMA200-39.03% Trades Volume13 Change-6.72%
Jun-20-24 06:32AM
May-21-24 01:45AM
May-16-24 01:45AM
Apr-17-24 05:00AM
Apr-11-24 02:10AM
02:30AM Loading…
Apr-08-24 02:30AM
Apr-05-24 02:30AM
Mar-14-24 10:40AM
Feb-01-24 02:30AM
Dec-19-23 02:36AM
Nov-27-23 02:00AM
Nov-06-23 01:48AM
Oct-23-23 01:00AM
Sep-26-23 02:43AM
Sep-21-23 07:54AM
01:34AM Loading…
Sep-11-23 01:34AM
Sep-06-23 08:00AM
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.